As CEO at Additional Ventures, Kirstie leads the organization’s strategy on how to cure patients with single ventricle heart defects. Working together with the science, engineering, and clinical communities, Additional Ventures is a nonprofit focused on placing big bets by taking risks on promising and innovative ideas to improve the quality and duration of life for these patients.

‍